Stock Market & Financial News

Loading...
V2X, Inc. (VVX) Q4 2025 Earnings Call Transcript

V2X, Inc. (VVX) Q4 2025 Earnings Call Transcript

V2X, Inc. (VVX) Q4 2025 Earnings Call Transcript

Seekingalpha | 9 hours ago

China's BYD Opens 2026 With Blockbuster Sales Growth in Europe

The auto giant logged a nearly threefold increase in European sales last month, as its electric and hybrid vehicles remained in high demand on the continent.

Wsj | 9 hours ago

Baytex Energy: We Will Now See How Effective The Strategy Change Is

Baytex Energy sold its Eagle Ford acreage at a loss. The transaction, along with deleveraging, has been well received by the market. Advances in heavy oil technology have made BTE's Clearwater basin operations notably profitable even (possibly) during downturns.

Seekingalpha | 9 hours ago

Calix Limited (CLXLF) Q2 2026 Earnings Call Transcript

Calix Limited (CLXLF) Q2 2026 Earnings Call Transcript

Seekingalpha | 10 hours ago
Novo's stumbles burnish Lilly's widening lead in weight-loss drugs

Novo's stumbles burnish Lilly's widening lead in weight-loss drugs

With U.S. arch rival Eli Lilly streaking away on weight-loss prescriptions and valuation, the last thing Novo Nordisk needed was to give it a helping hand. Then came the latest trial data for the Danish company's next-generation obesity drug.

Reuters | 10 hours ago
Oil Price Forecast: Middle East Tensions Keep WTI and Brent Poised for Breakout

Oil Price Forecast: Middle East Tensions Keep WTI and Brent Poised for Breakout

Oil prices remain supported by Middle East tensions and uncertain U.S.–Iran talks, while trade policy risks cap demand, keeping the outlook bullish if WTI breaks $68–$70 and Brent clear $72–$74.

Fxempire | 10 hours ago
Keysight Technologies Proves To Be An AI Winner

Keysight Technologies Proves To Be An AI Winner

Keysight Technologies delivered a blowout Q1, with revenue up 23% and record orders, driven by AI and semiconductor demand. Growth was broad-based across geographies and segments, with communications, defense, and semiconductors leading acceleration. Management raised guidance, targeting Q2 revenue up 30% and EPS up 35%, far above consensus estimates.

Seekingalpha | 10 hours ago
ACV Auctions Inc. (ACVA) Q4 2025 Earnings Call Transcript

ACV Auctions Inc. (ACVA) Q4 2025 Earnings Call Transcript

ACV Auctions Inc. (ACVA) Q4 2025 Earnings Call Transcript

Seekingalpha | 10 hours ago
Standard Chartered's Quarterly Profit Falls on Weak Interest Income

Standard Chartered's Quarterly Profit Falls on Weak Interest Income

The lender exceeded its aim of 13% return on tangible equity, a key profitability target, in 2025, hitting the goal a year earlier than initially planned.

Wsj | 10 hours ago
Kratos Defense & Security Solutions, Inc. (KTOS) Q4 2025 Earnings Call Transcript

Kratos Defense & Security Solutions, Inc. (KTOS) Q4 2025 Earnings Call Transcript

Kratos Defense & Security Solutions, Inc. (KTOS) Q4 2025 Earnings Call Transcript

Seekingalpha | 10 hours ago

Scentre Group (STGPF) Q4 2025 Earnings Call Transcript

Scentre Group (STGPF) Q4 2025 Earnings Call Transcript

Seekingalpha | 10 hours ago

Dow Jones & Nasdaq 100: Asian Markets Gain as US Futures Rebound

Asian markets gain as Nikkei 225 and CSI 300 advance, while US futures steady in the Asian session amid Fed rate cut bets and tariff risks.

Fxempire | 10 hours ago

Sprouts Farmers Market: Expectations Reset, Opportunity Emerging

Sprouts Farmers Market now trades at a P/E of 12 after a sharp correction from overvalued highs, presenting a compelling entry point. Comparable sales growth has normalized, with 2026 guidance of -1% to +1%, reflecting tough comps and moderating food inflation. My conservative model projects a 12% annual return over five years, with upside from accelerated share buybacks and potential multiple expansion.

Seekingalpha | 10 hours ago

Tennant (TNC) Lags Q4 Earnings and Revenue Estimates

Tennant (TNC) came out with quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.52 per share a year ago.

Zacks | 10 hours ago

LARK Distilling Co. Ltd. (LRKKF) Q2 2026 Earnings Call Transcript

LARK Distilling Co. Ltd. (LRKKF) Q2 2026 Earnings Call Transcript

Seekingalpha | 10 hours ago

BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript

Seekingalpha | 11 hours ago

Ingenia Communities Group Stapled Units (INGEF) Q2 2026 Earnings Call Transcript

Ingenia Communities Group Stapled Units (INGEF) Q2 2026 Earnings Call Transcript

Seekingalpha | 11 hours ago

Dover: Trading At A Discount To Industrial - Reiterate A Buy

Dover Corporation is reiterated as a BUY with a $240 price target, reflecting strong 2025 results and positive 2026 guidance. All five segments are expected to deliver positive organic growth and incremental margins in 2026, supported by easing tariffs and robust Capex cycles. DOV's efficiency improvements and acquisition synergies have driven margin expansion, with management guiding for 16%-18% FCF yield and adjusted EPS of $10.45-$10.65 in FY 2026.

Seekingalpha | 11 hours ago

Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call Transcript

Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call Transcript

Seekingalpha | 11 hours ago

QuickFee Limited (QFEFF) Q2 2026 Earnings Call Transcript

QuickFee Limited (QFEFF) Q2 2026 Earnings Call Transcript

Seekingalpha | 11 hours ago

Meta executive warned Facebook Messenger encryption plan was 'so irresponsible', shows court filing

Meta executives proceeded with a plan to encrypt the messaging services connected to its Facebook and Instagram apps despite internal warnings that it would hinder the social media giant's ability to flag child-exploitation cases to law enforcement, according to internal company documents filed in a New Mexico state court case.

Reuters | 11 hours ago

FedEx sues Trump administration for full tariff refunds after Supreme Court ruling on IEEPA

FedEx sues U.S. government for tariff refunds after Supreme Court ruled Trump's emergency trade duties on imports were unlawful.

Foxbusiness | 11 hours ago

Electromed: Some Short Term Gain But I Fear Long Term Pain

Electromed (ELMD) has delivered strong revenue growth and margin improvement, but faces a highly competitive, fragmented market for its SmartVest product. ELMD lacks a durable moat, with rivals like Tactile Medical and Baxter showing stronger brand recognition, technological advantages, and higher recent growth rates. Scientific evidence questions the comparative efficacy of HFCWO versus alternative airway clearance therapies, undermining the long-term growth thesis for SmartVest.

Seekingalpha | 11 hours ago

Ovintiv (OVV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Ovintiv (OVV) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 11 hours ago

Compared to Estimates, Black Stone Minerals (BSM) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Black Stone Minerals (BSM) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 11 hours ago

Atlas Energy Solutions Inc. (AESI) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Atlas Energy Solutions Inc. (AESI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 11 hours ago

Compared to Estimates, EverQuote (EVER) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for EverQuote (EVER) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 11 hours ago

Pfizer in diabetes drug deal with Sciwind Biosciences

Pfizer has entered an agreement to license Sciwind Biosciences' type 2 diabetes treatment ecnoglutide, with potential payments of up to $495 million if milestones are met, the Chinese drugmaker said on Tuesday.

Reuters | 11 hours ago

AUB Group Limited (AUBBF) Q2 2026 Earnings Call Transcript

AUB Group Limited (AUBBF) Q2 2026 Earnings Call Transcript

Seekingalpha | 11 hours ago

Zscaler Scales Zero Trust And AI Agent Security

Zscaler (ZS) is a compelling buy, trading at a compressed multiple, despite strong growth and a robust data moat in cloud security. ZS benefits from high gross retention, rapid AI/data security expansion, and dominant positioning in AI-agent security, following recent acquisitions. Short-term margin pressure and dilution from acquisitions are outweighed by long-term operating leverage and accelerating revenue growth.

Seekingalpha | 11 hours ago
Load More
Loading...